Hesse A - Search Results

1

Hypocitraturia as a risk factor for nephrocalcinosis after kidney transplantation.

Stapenhorst L, Sassen R, Beck B, Laube N, Hesse A, Hoppe B. Stapenhorst L, et al. Among authors: hesse a. Pediatr Nephrol. 2005 May;20(5):652-6. doi: 10.1007/s00467-005-1831-y. Epub 2005 Mar 22. Pediatr Nephrol. 2005. PMID: 15782300

2

Hypocitraturia is one of the major risk factors for nephrocalcinosis in very low birth weight (VLBW) infants.

Sikora P, Roth B, Kribs A, Michalk DV, Hesse A, Hoppe B. Sikora P, et al. Among authors: hesse a. Kidney Int. 2003 Jun;63(6):2194-9. doi: 10.1046/j.1523-1755.2003.t01-4-00001.x. Kidney Int. 2003. PMID: 12753307 Free article.

3

Urinary NAG in children with urolithiasis, nephrocalcinosis, or risk of urolithiasis.

Sikora P, Glatz S, Beck BB, Stapenhorst L, Zajaczkowska M, Hesse A, Hoppe B. Sikora P, et al. Among authors: hesse a. Pediatr Nephrol. 2003 Oct;18(10):996-9. doi: 10.1007/s00467-003-1229-7. Epub 2003 Aug 13. Pediatr Nephrol. 2003. PMID: 12920632

4

Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.

Hoppe B, von Unruh GE, Blank G, Rietschel E, Sidhu H, Laube N, Hesse A. Hoppe B, et al. Among authors: hesse a. Am J Kidney Dis. 2005 Sep;46(3):440-5. doi: 10.1053/j.ajkd.2005.06.003. Am J Kidney Dis. 2005. PMID: 16129205

5

Hyperoxaluria after ethylene glycol poisoning.

Stapenhorst L, Hesse A, Hoppe B. Stapenhorst L, et al. Among authors: hesse a. Pediatr Nephrol. 2008 Dec;23(12):2277-9. doi: 10.1007/s00467-008-0917-8. Epub 2008 Aug 12. Pediatr Nephrol. 2008. PMID: 18696123

6

Enteric hyperoxaluria, recurrent urolithiasis, and systemic oxalosis in patients with Crohn's disease.

Hueppelshaeuser R, von Unruh GE, Habbig S, Beck BB, Buderus S, Hesse A, Hoppe B. Hueppelshaeuser R, et al. Among authors: hesse a. Pediatr Nephrol. 2012 Jul;27(7):1103-9. doi: 10.1007/s00467-012-2126-8. Epub 2012 Feb 25. Pediatr Nephrol. 2012. PMID: 22366809

7

Urinary excretion substances in patients with cystic fibrosis: risk of urolithiasis?

Hoppe B, Hesse A, Brömme S, Rietschel E, Michalk D. Hoppe B, et al. Among authors: hesse a. Pediatr Nephrol. 1998 May;12(4):275-9. doi: 10.1007/s004670050452. Pediatr Nephrol. 1998. PMID: 9655356 Clinical Trial.

8

Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?

Laube N, Jansen B, Hesse A. Laube N, et al. Among authors: hesse a. Urol Res. 2002 Oct;30(5):336-41. doi: 10.1007/s00240-002-0272-3. Epub 2002 Aug 30. Urol Res. 2002. PMID: 12389124

9

Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria.

Hoppe B, Leumann E, von Unruh G, Laube N, Hesse A. Hoppe B, et al. Among authors: hesse a. Front Biosci. 2003 Sep 1;8:e437-43. doi: 10.2741/1135. Front Biosci. 2003. PMID: 12957811 Review.

10

The alteration of urine composition due to stone material present in the urinary tract.

Laube N, Pullmann M, Hergarten S, Schmidt M, Hesse A. Laube N, et al. Among authors: hesse a. Eur Urol. 2003 Nov;44(5):595-9. doi: 10.1016/s0302-2838(03)00365-8. Eur Urol. 2003. PMID: 14572760

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

393 results

Search Page

Filters